Month: November 2022

On January 4, 2022, Hu, Shuanghua; Lin, Zhaiwei; Cui, Baicheng published a patent.Name: Ethyl 3-fluoro-2-methylbenzoate The title of the patent was Preparation of pyridazinone derivatives and its application as anti-influenza drugs with CEN inhibitory effect. And the patent contained the following:

The present invention relates to the preparation of pyridazinone derivatives and its application as anti-influenza drugs with CEN inhibitory effect. In particular, the pyridazinone derivative I (wherein, R1 = H or, -C(=O)Y1, -C(=O)-O-Y1, etc.; Y1 = optionally substituted C1-10 alkyl, optionally substituted C3-8 cycloalkyl, optionally substituted aryl, etc.; where R* and R** = H or optionally substituted C1-6 alkyl; R2 and R3 = H, C1-6 alkyl, -C(O)-C1-6 alkyl, etc.; where R* and R** = H and optionally substituted C1-6 alkyl; q is 0-6; R4 = compound II; R9 and R10 = optionally substituted aryl, and optionally substituted heteroaryl; wherein the substituents are independent C1-6 alkyl, -C(O)- C1-6 alkyl, etc.; where R* and R** = H and optionally substituted C1-6 alkyl, and q is 0-6; R9 and R10 = linked to form the compound III; wherein n and m = 0-3, Q = CR*R**, NR*, O, S, SO, SO2; R* and R** = H and optionally substituted C1-6 alkyl;). Further, (R5 and R6 = H, or is selected from optionally substituted C1-8 alkyl, optionally substituted C2-8 alkenyl, etc.; wherein R* and R** = H and optionally substituted C1-6 alkyl, and q is 0-6; R7 and R8 = H, C1-6 alkyl, -C(O)- C1-6 alkyl, etc.; R* and R** = H and optionally substituted C1-6 alkyl; q is 0-6; R5, R7 or R6, R8 can be connected into a 5-8 membered saturated or unsaturated ring, such as a 6-membered ring, the ring may be a carbocyclic ring, or a heterocyclic ring containing O or N) or its pharmaceutically acceptable salts, solvates, hydrates, polycrystals, prodrugs, co-crystals, tautomers, stereoisomers, were prepared The inventive pyridazinone derivatives can be used as anti-influenza drugs with CEN inhibitory effect. The experimental process involved the reaction of Ethyl 3-fluoro-2-methylbenzoate(cas: 114312-57-1).Name: Ethyl 3-fluoro-2-methylbenzoate

The Article related to pyridazinone derivative preparation antiinfluenza drug cen inhibitor, Heterocyclic Compounds (More Than One Hetero Atom): Pyridazines, Cinnolines, and Phthalazines and other aspects.Name: Ethyl 3-fluoro-2-methylbenzoate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Choliq, Azka Azkiya; Nakae, Rio; Watanabe, Mariko; Misaki, Tomonori; Fujita, Morifumi; Okamoto, Yasuaki; Sugimura, Takashi published an article in 2019, the title of the article was Enhanced Enantioselectivity Achieved at Low Hydrogen Pressure for the Asymmetric Hydrogenation of Methyl Acetoacetate over a Tartaric Acid NaBr-Modified Raney Nickel Catalyst: A Kinetic Study.Safety of (R)-Methyl 3-hydroxybutanoate And the article contains the following content:

To ensure high enantiopurity of the product, enantio-differentiating hydrogenation of Me acetoacetate over a (R,R)-tartaric acid-modified Raney nickel catalyst is normally performed under elevated H2-pressure (∼10 MPa). In this study, higher enantioselectivity than previously reported for Me acetoacetate was achieved (92% ee) under low H2-pressure of 0.42 MPa. Effects of reaction conditions on the enantioselectivity and hydrogenation rate were investigated using a low-pressure reaction system (<0.5 MPa of H2). It was found that impurities in the solvent greatly reduce the enantioselectivity of MAA. The low-pressure reaction system enabled a satisfactory kinetic approach. The reaction rate was well described by Langmuir-Hinshelwood formalism, verifying the previous assumption that the addition of adsorbed hydrogen to the substrate interacting with surface tartrate is a rate-determining step. The experimental process involved the reaction of (R)-Methyl 3-hydroxybutanoate(cas: 3976-69-0).Safety of (R)-Methyl 3-hydroxybutanoate

The Article related to methyl acetoacetate modified ni catalyst enantioselective hydrogenation kinetics, Physical Organic Chemistry: Oxidation-Reduction, Including Dehydrogenation and Hydrogenolysis and other aspects.Safety of (R)-Methyl 3-hydroxybutanoate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On March 31, 2017, Osawa, Tsutomu; Tanabe, Yuya; Fujiwara, Manabu published an article.Related Products of 3976-69-0 The title of the article was Sodium Ion as the Most Essential and Effective Element for the Enantio-Differentiating Hydrogenation of Prochiral Ketones over Tartaric Acid Modified Ni Catalyst. And the article contained the following:

In order to investigate the role of metal ions on a tartaric acid modified nickel catalyst, the enantiodifferentiating hydrogenations of Me acetoacetate and Me levulinate were carried out. The effects of the addition of 17 metal salts of acetic acid on the enantioselectivity and the hydrogenation rate were investigated during the hydrogenation of Me acetoacetate. Among the examined metal salts, the addition of NaBr caused the great increase in the enantioselectivity and the hydrogenation rate during the hydrogenations of both Me acetoacetate and Me levulinate. Based on the strength of the interaction between the metal salts of tartaric acid and the substrate, the sodium salts would have the strongest interaction with the substrate, hence, this would be attributed to the highest enantioselectivity and hydrogenation rate for the sodium salts of tartaric acid. The experimental process involved the reaction of (R)-Methyl 3-hydroxybutanoate(cas: 3976-69-0).Related Products of 3976-69-0

The Article related to ketoester enantioselective hydrogenation catalyst nickel tartaric acid sodium ion, Physical Organic Chemistry: Oxidation-Reduction, Including Dehydrogenation and Hydrogenolysis and other aspects.Related Products of 3976-69-0

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

da Silva, Erotides Capistrano; Arrington, Justine; Yau, Peter M.; Smith-Fleming, Kathryn M.; Canisso, Igor Frederico; da Costa Martins, Bianca published an article in 2021, the title of the article was Proteome composition of bovine amniotic membrane and its potential role in corneal healing.Application of 2358-84-1 And the article contains the following content:

To investigate the protein profile of bovine amniotic membranes (bAM) and to determine putative associations between protein composition in bAM and known corneal healing pathways. The bAM were acquired from normal full-term births (n = 10), processed, and stored at -80°C for two days. Subsequently, the frozen membranes were thawed at room temperature and prepared for proteomic exploration using high-resolution liquid chromatog.-mass spectrometry, followed by bioinformatics anal. Recently identified corneal healing pathways were contrasted with protein profiles and pathways present in bAM. Results. The analyses identified 2105 proteins, with an interactive network of 1271 nodes (proteins) and 8757 edges (interactions). The proteins with higher betweenness centrality measurements include microfibril-associated protein 4, HSD3B1, CAPNS1, ATP1B3, CAV1, ANXA2, YARS, and GAPDH. The top four pathways in Kyoto Encyclopedia of Genes and Genomes were ribosome, metabolic pathway, spliceosome, and oxidative phosphorylation. The bAM and cornea shared abundant proteins, genome ontol., and signaling pathways. The high-throughput proteomic profile of the bAM demonstrated that numerous proteins present in the cornea are also present in this fetal membrane. Our findings collectively demonstrate the similarity between bAM and the cornea’s protein composition, supporting our hypothesis that bAM can be used to treat corneal diseases. The experimental process involved the reaction of Oxybis(ethane-2,1-diyl) bis(2-methylacrylate)(cas: 2358-84-1).Application of 2358-84-1

The Article related to bovine amniotic membrane corneal healing proteome, Pharmacology: Effects Of Nervous System- and Behavior-Affecting Drugs and Neuromuscular Agents and other aspects.Application of 2358-84-1

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On May 10, 2022, Eren, Hamit; Bednarz, Roland Jan-Reiner; Alimoradi Jazi, Maryam; Donk, Laura; Gudjonsdottir, Solrun; Bohlaender, Peggy; Eelkema, Rienk; Houtepen, Arjan J. published an article.Safety of Oxybis(ethane-2,1-diyl) bis(2-methylacrylate) The title of the article was Permanent Electrochemical Doping of Quantum Dot Films through Photopolymerization of Electrolyte Ions. And the article contained the following:

Quantum dots (QDs) are considered for devices like light-emitting diodes (LEDs) and photodetectors as a result of their tunable optoelectronic properties. To utilize the full potential of QDs for optoelectronic applications, control over the charge carrier d. is vital. However, controlled electronic doping of these materials has remained a long-standing challenge, thus slowing their integration into optoelectronic devices. Electrochem. doping offers a way to precisely and controllably tune the charge carrier concentration as a function of applied potential and thus the doping levels in QDs. However, the injected charges are typically not stable after disconnecting the external voltage source because of electrochem. side reactions with impurities or with the surfaces of the QDs. Here, we use photopolymerization to covalently bind polymerizable electrolyte ions to polymerizable solvent mols. after electrochem. charge injection. We discuss the importance of using polymerizable dopant ions as compared to nonpolymerizable conventional electrolyte ions such as LiClO4 when used in electrochem. doping. The results show that the stability of charge carriers in QD films can be enhanced by many orders of magnitude, from minutes to several weeks, after photochem. ion fixation. We anticipate that this novel way of stable doping of QDs will pave the way for new opportunities and potential uses in future QD electronic devices. The experimental process involved the reaction of Oxybis(ethane-2,1-diyl) bis(2-methylacrylate)(cas: 2358-84-1).Safety of Oxybis(ethane-2,1-diyl) bis(2-methylacrylate)

The Article related to permanent electrochem doping quantum dot film photopolymerization electrolyte ion, Optical, Electron, and Mass Spectroscopy and Other Related Properties: Electronic Spectroscopy and other aspects.Safety of Oxybis(ethane-2,1-diyl) bis(2-methylacrylate)

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On May 13, 1994, Kulagowski, Janusz J.; Baker, Raymond; Curtis, Neil R.; Mawer, Ian M.; Moseley, Angela M.; Ridgill, Mark P.; Rowley, Michael; Stansfield, Ian; Leeson, Paul D. published an article.HPLC of Formula: 142327-44-4 The title of the article was 3′-(Arylmethyl)- and 3′-(Aryloxy)-3-phenyl-4-hydroxyquinolin- 2(1H)-ones: Orally Active Antagonists of the Glycine Site on the NMDA Receptor. And the article contained the following:

Antagonists acting at the glycine site of the N-methyl-D-aspartate (NMDA) receptor are expected to have considerable therapeutic potential in a variety of disorders of the central nervous system. However in vivo studies with currently available compounds are severely compromised by the poor activities observed following systemic administration. The authors have previously followed a strategy of carboxyl replacement in known antagonists to provide 7-chloro-4-hydroxy-3-phenylquinolin-2(1H)-one (I). The authors now show that optimization of I by substitution of the 3-Ph with selected hydrophobic 3′-substituents yields a 100-fold improvement of in vitro affinity (IC50 values for displacement of [3H]L-689,560 binding and Kb values in cortical slice), combined with potent systemic anticonvulsant activity in the DBA/2 mouse audiogenic seizure model (ED50 values obtained after i.p. (i.p.) and oral (p.o.) administration). The following 3′-derivatives of I were identified: 3′-(4-methoxybenzyl)- (L-703,717), IC50 4.5 nM, Kb 25 nM, ED50 0.7 mg/kg i.p. and 0.9 mg/kg p.o.; 3′-(4-(1-methoxy)methoxybenzyl)- (L-708,541), IC50 2.2 nM, Kb 3.2 nM, ED50 0.5 mg/kg i.p. and 0.9 mg/kg p.o.; 3′-phenoxy- (L-701,324), IC50 2.8 nM, Kb 28 nM, ED50 0.9 mg/kg i.p. and 0.9 mg/kg p.o.; and 3′-(3-thienyloxy)- (L-705,022), IC50 1.4 nM, Kb 5.0 nM< ED50 0.8 mg/kg i.p. and 0.8 mg/kg p.o. These new glycine antagonists are the most potent yet described, both in vitro and in vivo, and are the first with oral activity. The experimental process involved the reaction of Methyl 2-(3-formylphenyl)acetate(cas: 142327-44-4).HPLC of Formula: 142327-44-4

The Article related to nmda receptor glycine site antagonist hydroxyphenylquinolone, anticonvulsant phenylhydroxyquinolone preparation, Pharmacology: Effects Of Nervous System- and Behavior-Affecting Drugs and Neuromuscular Agents and other aspects.HPLC of Formula: 142327-44-4

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On June 15, 2018, Shimada, Kousei; Ohata, Yasuo; Kobayashi, Jun; Onishi, Yoshiyuki; Kawamura, Asuka; Domon, Yuki; Arakawa, Naohisa; Inoue, Tatsuya; Kitano, Yutaka; Matsuda, Fumihiko; Abe, Yuki; Deguchi, Tsuneo published an article.Recommanded Product: (R)-Methyl 3-hydroxybutanoate The title of the article was Alkylsulfanyl analogs as potent α2δ ligands. And the article contained the following:

The authors identified novel (3R, 5S)-3-aminomethyl-5-methanesulfanyl hexanoic acid (5a: DS75091588) and (3R, 5S)-3-aminomethyl-5-ethanesulfanyl hexanoic acid (6a: DS18430756) as sulfur-containing γ-amino acid derivatives that were useful for the treatment of neuropathic pain. These two compounds exhibited a potent analgesic effect in animal models of both type I diabetes and type II diabetes, and good pharmacokinetics. The experimental process involved the reaction of (R)-Methyl 3-hydroxybutanoate(cas: 3976-69-0).Recommanded Product: (R)-Methyl 3-hydroxybutanoate

The Article related to alkylsulfanyl analog preparation alpha2delta calcium channel neuropathic pain analgesic, alkylsulfanyl, analgesic, diabetes, α(2)δ, γ-amino acid, Pharmacology: Effects Of Nervous System- and Behavior-Affecting Drugs and Neuromuscular Agents and other aspects.Recommanded Product: (R)-Methyl 3-hydroxybutanoate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

Xiang, Cheng; Liao, Yilin; Chen, Zhuoyuan; Xiao, Bo; Zhao, Ziyue; Li, Aoyu; Xia, Yu; Wang, Pingxiao; Li, Hui; Xiao, Tao published an article in 2022, the title of the article was Network pharmacology and molecular docking to elucidate the potential mechanism of ligusticum chuanxiong against osteoarthritis.Safety of Oxybis(ethane-2,1-diyl) bis(2-methylacrylate) And the article contains the following content:

Osteoarthritis (OA) is a degenerative disease which serious affects patients. Ligusticum chuanxiong (CX) has been shown to have a certain curative effect on osteoarthritis in traditional Chinese medicine therapy. This study is based on network pharmacol. and mol. docking technol. to explore the potential mechanism of CX. Components of CX to treat osteoarthritis were screened in the TCMSP database and targets were predicted by the PharmMapper database, the osteoarthritis targets were collected from the GeneCards database, and intersection genes were found to be the possible targets of CX anti-OA. The STRING database and Cytoscape software were utilized for protein-protein interaction anal. and further screening of core targets. The Metascape database was used for KEGG and GO enrichment analyses. Then, the top 10 pathways were selected to construct “drug-compound-target-pathway-disease” network anal. Finally, mol. docking was used to analyze the binding affinity of seven compounds with core targets and TNF-α. Seven compounds with 253 non-repetitive targets of CX were screened fromthe TCMSP database and 60 potential intersection targets of CX anti-OA were found. PPI network anal. showed that the core targets were ALB, AKT1, IGF1, CASP3, MAPK1, ANXA5, and MAPK14, while GO and KEGG pathway enrichment analyses showed that the relevant biol. processes involved in the treatment of osteoarthritis by CX might include the MAPK cascade and reactive oxygen species metabolic process. The KEGG pathway anal. result was mainly associated with the MAPK signaling pathway and PI3K-AKT signaling pathway. We further docked seven ingredients with MAPK1 and MAPK14 enriched in the MAPK pathway, and TNF-α as the typical inflammatory cytokine. The results also showed good binding affinity, especially FA, which may be the most important component of CX anti-OA. Our research revealed the potential mechanism of CX in the treatment of OA, and our findings can also pave the way for subsequent basic exptl. verification and a new research direction. The experimental process involved the reaction of Oxybis(ethane-2,1-diyl) bis(2-methylacrylate)(cas: 2358-84-1).Safety of Oxybis(ethane-2,1-diyl) bis(2-methylacrylate)

The Article related to ligusticum chuanxiong pharmacol mol docking osteoarthritis, mapk pathway, ligusticum chuanxiong, molecular docking, network pharmacology, osteoarthritis, Pharmacology: Effects Of Nervous System- and Behavior-Affecting Drugs and Neuromuscular Agents and other aspects.Safety of Oxybis(ethane-2,1-diyl) bis(2-methylacrylate)

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On June 30, 2021, Coppi, Elisabetta; Buonvicino, Daniela; Ranieri, Giuseppe; Cherchi, Federica; Venturini, Martina; Pugliese, Anna Maria; Chiarugi, Alberto published an article.Name: 2-Ethylhexyl 2-cyano-3,3-diphenylacrylate The title of the article was Dexpramipexole Enhances K+ Currents and Inhibits Cell Excitability in the Rat Hippocampus In Vitro. And the article contained the following:

Dexpramipexole (DEX) has been described as the first-in-class F1Fo ATP synthase activator able to boost mitochondrial bioenergetics and provide neuroprotection in exptl. models of ischemic brain injury. Although DEX failed in a phase III trial in patients with amyotrophic lateral sclerosis, it showed favorable safety and tolerability profiles. Recently, DEX emerged as a Nav1.8 Na+ channel and transient outward K+ (IA) conductance blocker, revealing therefore an unexpected, pleiotypic pharmacodynamic profile. In this study, we performed electrophysiol. experiments in vitro aimed to better characterize the impact of DEX on voltage-dependent currents and synaptic transmission in the hippocampus. By means of patch-clamp recordings on isolated hippocampal neurons, we found that DEX increases outward K+ currents evoked by a voltage ramp protocol. This effect is prevented by the non-selective voltage-dependent K+ channel (Kv) blocker TEA and by the selective small-conductance Ca2+-activated K+ (SK) channel blocker apamin. In keeping with this, extracellular field recordings from rat hippocampal slices also demonstrated that the compound inhibits synaptic transmission and CA1 neuron excitability. Overall, these data further our understanding on the pharmacodynamics of DEX and disclose an addnl. mechanism that could underlie its neuroprotective properties. Also, they identify DEX as a lead to develop new modulators of K+ conductances. The experimental process involved the reaction of 2-Ethylhexyl 2-cyano-3,3-diphenylacrylate(cas: 6197-30-4).Name: 2-Ethylhexyl 2-cyano-3,3-diphenylacrylate

The Article related to dexpramipexole potassium ion cell excitability hippocampus, hippocampal neurons, k+ channels, neuronal excitability, population spike, synaptic transmission, Pharmacology: Effects Of Nervous System- and Behavior-Affecting Drugs and Neuromuscular Agents and other aspects.Name: 2-Ethylhexyl 2-cyano-3,3-diphenylacrylate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics

On July 31, 2021, Owen, Benjamin; Bichler, Edyta; Benveniste, Morris published an article.Name: 2-Ethylhexyl 2-cyano-3,3-diphenylacrylate The title of the article was Excitatory synaptic transmission in hippocampal area CA1 is enhanced then reduced as chronic epilepsy progresses. And the article contained the following:

This study examines changes in synaptic transmission with progression of the chronic epileptic state. Male Sprague-Dawley rats (P40-45) were injected with either saline or pilocarpine. In rats injected with pilocarpine, status epilepticus ensued. Hippocampal slices were cut 20-60 days or 80-110 days post-treatment. Evoked and miniature EPSCs (mEPSCs) were recorded from CA1 pyramidal neurons using whole-cell voltage-clamp. Fiber volleys were also recorded from stratum radiatum. Evoked EPSCs from the pilocarpine-treated cohort showed enhanced amplitudes 20-60 days post-treatment compared to the saline-treated cohort, whereas mEPSCs recorded from the same age group showed no change in event frequency and a slight but significant decrease in mEPSC amplitude distribution. In contrast, comparing evoked EPSCs and mEPSCs recorded 80-110 days after treatment indicated reduced amplitudes from pilocarpine-treated animals compared to controls. mEPSC inter-event interval decreased. This could be explained by a partial depletion of the ready releasable pool of neurotransmitter vesicles in Schaffer collateral presynaptic terminals of the pilocarpine-treated rats. In both saline- and pilocarpine-treated cohorts, concomitant decreases in mEPSC amplitudes as time after treatment progressed suggest that age-related changes in CA1 circuitry may be partially responsible for changes in synaptic transmission that may influence the chronic epileptic state. The experimental process involved the reaction of 2-Ethylhexyl 2-cyano-3,3-diphenylacrylate(cas: 6197-30-4).Name: 2-Ethylhexyl 2-cyano-3,3-diphenylacrylate

The Article related to pilocarpine ca1 antiepilepsy agent chronic epilepsy, aging, epscs, epilepsy, fiber volleys, hippocampus, pilocarpine, status epilepticus, synaptic transmission, mepscs, Pharmacology: Effects Of Nervous System- and Behavior-Affecting Drugs and Neuromuscular Agents and other aspects.Name: 2-Ethylhexyl 2-cyano-3,3-diphenylacrylate

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics